Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FPT-20 for Spermatogenic Failure
NCT05399212Completed
- Start
- Oct 2020
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of FPT-20 in spermatogenic failure and male infertility. Primary endpoint: Sperm count in semen at 180 days. Started Oct 2020; status: completed.
02
Drugs
FPT-20
03
Conditions
spermatogenic failuremale infertility
Beyond the preview
Go deeper on NCT05399212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05399212.